Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
NCT00769028Phase 2Unknown
- Sponsor
- Daval International Ltd
- Start
- Dec 2008
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AIMSPRO in diffuse cutaneous systemic sclerosis (dcSSc), sponsored by Daval International Ltd. Status: unknown.
02
Drugs
AIMSPRO
03
Conditions
diffuse cutaneous systemic sclerosis (dcSSc)
Beyond the preview
Go deeper on NCT00769028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769028.